Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine ...

Researchers developed and validated a label-free, non-invasive method combining AFM with deep learning for accurate profiling ...

When the lungs are attacked by a virus, the damage doesn't stop there. The body's natural defenses cause inflammation while ...

Toll-like receptors (TLRs) shape trained immunity, balancing infection responses and chronic inflammation, and TLR agonists are promising immunomodulators for infectious diseases and cancer.

Lung tumors don't just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and collaborators report in the September 10 online issue of ...

New findings reveal how cancer manipulates immune pathways and highlight therapeutic strategies to unleash T-cells against even the most resistant tumors. Study: Cancer cells impair monocyte-mediated ...

Five signaling subtypes identified by NMF clustering. Subtype 5 (high APsig) correlates with immune-rich "hot" tumors, while Subtype 2 (low APsig) exhibits metabolic reprogramming and hypoxia. High ...